Correlation Between SAB Biotherapeutics and Oncternal Therapeutics
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Oncternal Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Oncternal Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Oncternal Therapeutics, you can compare the effects of market volatilities on SAB Biotherapeutics and Oncternal Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Oncternal Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Oncternal Therapeutics.
Diversification Opportunities for SAB Biotherapeutics and Oncternal Therapeutics
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between SAB and Oncternal is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Oncternal Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncternal Therapeutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Oncternal Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncternal Therapeutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Oncternal Therapeutics go up and down completely randomly.
Pair Corralation between SAB Biotherapeutics and Oncternal Therapeutics
Given the investment horizon of 90 days SAB Biotherapeutics is expected to generate 0.8 times more return on investment than Oncternal Therapeutics. However, SAB Biotherapeutics is 1.24 times less risky than Oncternal Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Oncternal Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 600.00 in SAB Biotherapeutics on August 28, 2024 and sell it today you would lose (297.00) from holding SAB Biotherapeutics or give up 49.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
SAB Biotherapeutics vs. Oncternal Therapeutics
Performance |
| Timeline |
| SAB Biotherapeutics |
| Oncternal Therapeutics |
SAB Biotherapeutics and Oncternal Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SAB Biotherapeutics and Oncternal Therapeutics
The main advantage of trading using opposite SAB Biotherapeutics and Oncternal Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Oncternal Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncternal Therapeutics will offset losses from the drop in Oncternal Therapeutics' long position.| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
| Oncternal Therapeutics vs. CytomX Therapeutics | Oncternal Therapeutics vs. Assembly Biosciences | Oncternal Therapeutics vs. Instil Bio | Oncternal Therapeutics vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |